Consolidated Balance Sheet (USD $)	Dec. 31, 2011	Dec. 31, 2010
Current assets:
Cash and cash equivalents	$ 3,196,831	$ 2,470,852
Short term investments	5,000,000	5,360,970
Accounts receivable, net	3,236,917	1,986,125
Income tax receivable	244,720	185,386
Deferred tax asset	1,309,801	0
Prepaid expenses and other current assets	98,233	91,925
Total current assets	13,086,503	10,095,258
Deferred royalty buy-down	1,250,000	1,250,000
Deferred tax assets -long term	1,738,154	0
Patent costs, net	190,416	173,443
Total assets	16,265,073	11,518,701
Current liabilities:
Accounts payable and accrued expenses	601,002	893,083
Accrued third party development expenses	0	2,649,369
Deferred revenue	437,099	483,769
Accrued liabilities of discontinued operations	78,138	78,138
Total current liabilities	1,116,239	4,104,359
Deferred revenue - license fees	276,520	713,619
Stockholders' equity:
Series A Preferred stock, $.50 par value, 700,000 shares authorized; none outstanding	0	0
Common stock, $.001 par value; 10,000,000 shares authorized; 6,530,743 and 6,445,743shares issued at December 31, 2011 and 2010, respectively	6,531	6,446
Additional paid-in capital	20,049,196	17,739,765
Accumulated deficit	(3,291,904)	(9,893,530)
Treasury stock, 194,604 and 151,875 shares at cost as of December 31, 2011 and 2010	(1,891,509)	(1,151,958)
Total stockholders' equity	14,872,314	6,700,723
Total liabilities and stockholders' equity	$ 16,265,073	$ 11,518,701